Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tuulia Vallius, M.D., Ph.D.

Concepts (67)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms, Glandular and Epithelial320174871.140 Why?
Ovarian Neoplasms5201948750.570 Why?
CA-125 Antigen220172800.520 Why?
Fluorodeoxyglucose F183201820070.440 Why?
Tumor Burden1201818970.390 Why?
Proteins2201760300.360 Why?
Neoadjuvant Therapy2201828110.330 Why?
Radiopharmaceuticals2201726330.330 Why?
Antineoplastic Combined Chemotherapy Protocols32020117080.200 Why?
Chemotherapy, Adjuvant3202035310.160 Why?
Pyrimidinones120203830.150 Why?
Organoplatinum Compounds220184100.150 Why?
Cisplatin2202016420.140 Why?
Receptors, Progesterone1202111220.130 Why?
Tumor Microenvironment2202438260.110 Why?
Receptors, Estrogen1202122020.110 Why?
Single-Cell Analysis1202423680.110 Why?
Neoplasm Staging22017111410.090 Why?
Receptor, erbB-21202125440.090 Why?
Positron-Emission Tomography2201864570.090 Why?
Postoperative Care1201714780.090 Why?
Pyrazoles1202019920.090 Why?
Cystadenocarcinoma, Serous120144750.090 Why?
Software1202444200.090 Why?
Drug Resistance, Neoplasm2201952300.070 Why?
Regression Analysis1201563610.070 Why?
Prognosis22018296360.060 Why?
Aged, 80 and over32018589470.060 Why?
Research Design1201961810.060 Why?
Melanoma1202256950.060 Why?
Tomography, X-Ray Computed22018204840.050 Why?
Skin Neoplasms1202257970.050 Why?
Aged520201689950.050 Why?
Female820213910110.050 Why?
Models, Statistical1201550730.050 Why?
Membrane Proteins1201778540.040 Why?
Humans1120247602610.040 Why?
Platinum120192230.040 Why?
Ecosystem120224860.040 Why?
Retrospective Studies22018803010.040 Why?
Reproducibility of Results12015200480.040 Why?
Mammals1202211290.040 Why?
Models, Theoretical2201935610.030 Why?
Middle Aged420202201750.030 Why?
Prospective Studies22018542630.030 Why?
Taxoids120196680.030 Why?
Lymphocytes, Tumor-Infiltrating1202110900.030 Why?
Antineoplastic Agents12018136290.030 Why?
Cohort Studies12017413170.030 Why?
Cell Nucleus1202229090.030 Why?
Breast Neoplasms12021210650.030 Why?
Follow-Up Studies12014392540.030 Why?
Drug Combinations1201820240.030 Why?
Computational Biology1202435040.020 Why?
Protein-Tyrosine Kinases1202024150.020 Why?
Cell Cycle Proteins1202034480.020 Why?
Adult320202198470.020 Why?
Kaplan-Meier Estimate1201965450.020 Why?
Treatment Outcome12014649470.020 Why?
Cytokines1202273450.020 Why?
Computer Simulation1201962100.020 Why?
Image Processing, Computer-Assisted1202289450.020 Why?
Clinical Trials as Topic1201980580.010 Why?
Apoptosis1201994970.010 Why?
Neoplasms12024220660.010 Why?
Young Adult12020586730.010 Why?
Animals120221679400.010 Why?
Vallius's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (67)
Explore
_
Co-Authors (28)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.